Kennondale Capital Management LLC Amylyx Pharmaceuticals, Inc. Transaction History
Kennondale Capital Management LLC
- $91.7 Billion
- Q1 2025
A detailed history of Kennondale Capital Management LLC transactions in Amylyx Pharmaceuticals, Inc. stock. As of the latest transaction made, Kennondale Capital Management LLC holds 202,743 shares of AMLX stock, worth $993,440. This represents 0.78% of its overall portfolio holdings.
Number of Shares
202,743
Previous 134,445
50.8%
Holding current value
$993,440
Previous $508 Million
41.23%
% of portfolio
0.78%
Previous 0.55%
Shares
2 transactions
Others Institutions Holding AMLX
# of Institutions
143Shares Held
48.9MCall Options Held
281KPut Options Held
438K-
Perceptive Advisors LLC New York, NY6.77MShares$33.2 Million0.85% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA4.64MShares$22.8 Million2.86% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.69MShares$13.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$13.1 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC2.43MShares$11.9 Million0.0% of portfolio
About Amylyx Pharmaceuticals, Inc.
- Ticker AMLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,533,200
- Market Cap $287M
- Description
- Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...